Related Experiment Video
Updated: Aug 18, 2026

Amikacin Protection Assay for Quantification and Visualization of Escherichia coli Cell Invasion
Published on: July 3, 2026
Gentamicin induced ototoxicity during treatment of enterococcal endocarditis: resolution with substitution by
J E East1, J E Foweraker, F D Murgatroyd
1Papworth Hospital, Papworth Everard, Cambridge, UK.
Abstract:
Enterococcal endocarditis can be very difficult to eradicate, requiring prolonged treatment with a combination of a penicillin and an aminoglycoside. In this patient with a pacemaker associated enterococcal endocarditis, ototoxicity occurred due to total gentamicin dose despite plasma concentrations consistently within the treatment range. Substitution with netilmicin, without a break in aminoglycoside treatment, resulted in a rapid improvement in hearing and allowed the required course of aminoglycoside to be completed. The risk factors for ototoxicity with gentamicin are reviewed, in particular the dangers of increasing age and of multiple and prolonged courses. Close treatment monitoring does not totally avoid this risk, especially when prolonged aminoglycoside treatment is required. This case emphasises the need for prompt investigation and adequate, definitive treatment of enterococcal endocarditis to avoid the increased risk consequent on repeated courses of antibiotics. The resolution of the ototoxicity with netilmicin is consistent with other reports of lower cochleotoxicity than with other aminoglycosides.
Related Concept Videos
Endocarditis III: Medical Management
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Endocarditis IV: Nursing Management
Myocarditis III: Medical Management
Endocarditis I: Introduction
Mitral Stenosis III: Medical Management